Bullous Pemphigoid as an Adverse Reaction to Pembrolizumab: Two Case Reports

• Main Authors: Kenneth Thomsen (Author), Jon Diernaes (Author), Trine Heide Øllegaard (Author), Eva Spaun (Author), Christian Vestergaard (Author)
• Format: Book
• Published: Karger Publishers, 2018-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Checkpoint inhibitors are novel and promising treatment options for different types of cancer. Programmed cell death 1 (PD-1) inhibitors, such as pembrolizumab, have been shown to significantly raise the survival rates of disseminated malignant melanoma (MM). Autoimmune adverse reactions are very co...